{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:31:16Z","timestamp":1794346276245,"version":"4.9.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Primary sclerosing cholangitis (PSC) is a chronic inflammatory disease of the bile ducts that can lead to biliary cancer and end-stage liver disease. PSC is associated with inflammatory bowel disease and an altered gut microbiota. However, the molecular mechanisms underlying gut\u2013liver interactions in PSC remain poorly characterized. Here we show that the gut microbiota-derived metabolite imidazole propionate (ImP) is a disease driver in PSC. Individuals with PSC have higher circulating ImP levels than individuals with related conditions, and high ImP levels predict reduced survival in PSC. Cholangiocytes exposed to ImP show activated mammalian target of rapamycin complex 1 (mTORC1) signalling and secrete pro-inflammatory and pro-fibrogenic factors. Chronic administration of ImP to mice induces liver inflammation and fibrosis through a p38-dependent mechanism, upstream of mTORC1. We propose that chronic exposure to ImP induces cholangiocyte injury, which alone or in concert with other factors causes clinical worsening of PSC. Therefore, targeting ImP production or signalling may represent therapeutic avenues in PSC.<\/jats:p>","DOI":"10.1038\/s42255-026-01600-1","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:02:50Z","timestamp":1788512570000},"page":"1910-1925","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling"],"prefix":"10.1038","volume":"8","author":[{"given":"Antonio","family":"Molinaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0794-7737","authenticated-orcid":false,"given":"Peder Rust\u00f8en","family":"Braadland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8570-2519","authenticated-orcid":false,"given":"Guido","family":"Carpino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Nikolaidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Hanzely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina R.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8553-7744","authenticated-orcid":false,"given":"Ahmad H.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4736-0244","authenticated-orcid":false,"given":"Annika","family":"Lundqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Juran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3561-8903","authenticated-orcid":false,"given":"Diletta","family":"Overi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6926-7131","authenticated-orcid":false,"given":"Enya","family":"Amundsen\u2011Isaksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2018-7787","authenticated-orcid":false,"given":"Henrik Mikael","family":"Reims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Bj\u00f6rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Grzyb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Abildgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine","family":"Folseraas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7981-0927","authenticated-orcid":false,"given":"Martin","family":"Cornillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00f3lmfr\u00ed\u00f0ur","family":"Helgad\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan M.","family":"McCauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cristoferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Cardinale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0104-465X","authenticated-orcid":false,"given":"Marte L.","family":"H\u00f8ivik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Katrine","family":"Enges\u00e6ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1887-9255","authenticated-orcid":false,"given":"Sara K. V.","family":"Tj\u00f8nnfjord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per M.","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Vesterhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8289-9931","authenticated-orcid":false,"given":"Tom H.","family":"Karlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Gr\u00f8nb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Gaudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0437-681X","authenticated-orcid":false,"given":"Konstantinos N.","family":"Lazaridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6903-6878","authenticated-orcid":false,"given":"Espen","family":"Melum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"B\u00e4ckhed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5900-8096","authenticated-orcid":false,"given":"Johannes Roksund","family":"Hov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"1600_CR1","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen, T. H., Folseraas, T., Thorburn, D. & Vesterhus, M. Primary sclerosing cholangitis\u2014a comprehensive review. J. Hepatol. 67, 1298\u20131323 (2017).","journal-title":"J. Hepatol."},{"key":"1600_CR2","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0140-6736(25)02582-6","volume":"407","author":"E Seth","year":"2026","unstructured":"Seth, E. et al. Primary sclerosing cholangitis. Lancet 407, 1549\u20131569 (2026).","journal-title":"Lancet"},{"key":"1600_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101700","volume":"8","author":"B Mol","year":"2026","unstructured":"Mol, B. et al. Proctocolectomy with permanent ileostomy is associated with improved transplant-free survival in patients with PSC. JHEP Rep. 8, 101700 (2026).","journal-title":"JHEP Rep."},{"key":"1600_CR4","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/HEP.0000000000000506","volume":"80","author":"KM Schneider","year":"2024","unstructured":"Schneider, K. M., Kummen, M., Trivedi, P. J. & Hov, J. R. Role of microbiome in autoimmune liver diseases. Hepatology 80, 965\u2013987 (2024).","journal-title":"Hepatology"},{"key":"1600_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","volume":"66","author":"M Kummen","year":"2017","unstructured":"Kummen, M. et al. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls. Gut 66, 611\u2013619 (2017).","journal-title":"Gut"},{"key":"1600_CR6","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","volume":"65","author":"J Sabino","year":"2016","unstructured":"Sabino, J. et al. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD. Gut 65, 1681\u20131689 (2016).","journal-title":"Gut"},{"key":"1600_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.32773","volume":"77","author":"MJ Hole","year":"2023","unstructured":"Hole, M. J. et al. A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation. Hepatology 77, 715\u2013728 (2023).","journal-title":"Hepatology"},{"key":"1600_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","volume":"4","author":"N Nakamoto","year":"2019","unstructured":"Nakamoto, N. et al. Gut pathobionts underlie intestinal barrier dysfunction and liver T\u2009helper 17 cell immune response in primary sclerosing cholangitis. Nat. Microbiol. 4, 492\u2013503 (2019).","journal-title":"Nat. Microbiol."},{"key":"1600_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41575-022-00690-y","volume":"20","author":"JR Hov","year":"2023","unstructured":"Hov, J. R. & Karlsen, T. H. The microbiota and the gut\u2013liver axis in primary sclerosing cholangitis. Nat. Rev. Gastroenterol. Hepatol. 20, 135\u2013154 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1600_CR10","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1053\/j.gastro.2020.12.058","volume":"160","author":"M Kummen","year":"2021","unstructured":"Kummen, M. et al. Altered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis. Gastroenterology 160, 1784\u20131798.e0 (2021).","journal-title":"Gastroenterology"},{"key":"1600_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41586-020-2896-2","volume":"588","author":"N Bar","year":"2020","unstructured":"Bar, N. et al. A reference map of potential determinants for the human serum metabolome. Nature 588, 135\u2013140 (2020).","journal-title":"Nature"},{"key":"1600_CR12","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s41591-023-02248-0","volume":"29","author":"K Watanabe","year":"2023","unstructured":"Watanabe, K. et al. Multiomic signatures of body mass index identify heterogeneous health phenotypes and responses to a lifestyle intervention. Nat. Med. 29, 996\u20131008 (2023).","journal-title":"Nat. Med."},{"key":"1600_CR13","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cell.2018.09.055","volume":"175","author":"A Koh","year":"2018","unstructured":"Koh, A. et al. Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell 175, 947\u2013961.e17 (2018).","journal-title":"Cell"},{"key":"1600_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jchf.2023.03.008","volume":"11","author":"A Molinaro","year":"2023","unstructured":"Molinaro, A. et al. Microbially produced imidazole propionate is associated with heart failure and mortality. JACC Heart Fail. 11, 810\u2013821 (2023).","journal-title":"JACC Heart Fail."},{"key":"1600_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108092","volume":"26","author":"S Zheng","year":"2023","unstructured":"Zheng, S. et al. Microbiota-derived imidazole propionate inhibits type 2 diabetic skin wound healing by targeting SPNS2-mediated S1P transport. iScience 26, 108092 (2023).","journal-title":"iScience"},{"key":"1600_CR16","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jhep.2023.05.038","volume":"79","author":"PR Braadland","year":"2023","unstructured":"Braadland, P. R. et al. Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation. J. Hepatol. 79, 955\u2013966 (2023).","journal-title":"J. Hepatol."},{"key":"1600_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19589-w","volume":"11","author":"A Molinaro","year":"2020","unstructured":"Molinaro, A. et al. Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology. Nat. Commun. 11, 5881 (2020).","journal-title":"Nat. Commun."},{"key":"1600_CR18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI186423","volume":"135","author":"B Schnabl","year":"2025","unstructured":"Schnabl, B., Damman, C. J. & Carr, R. M. Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations. J. Clin. Invest. 135, e186423 (2025).","journal-title":"J. Clin. Invest."},{"key":"1600_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos, A., de Gottardi, A. & Rescigno, M. The gut\u2013liver axis in liver disease: pathophysiological basis for therapy. J. Hepatol. 72, 558\u2013577 (2020).","journal-title":"J. Hepatol."},{"key":"1600_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","volume":"16","author":"JM Banales","year":"2019","unstructured":"Banales, J. M. et al. Cholangiocyte pathobiology. Nat. Rev. Gastroenterol. Hepatol. 16, 269\u2013281 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1600_CR21","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.molmet.2017.08.016","volume":"6","author":"A Molinaro","year":"2017","unstructured":"Molinaro, A. et al. Host\u2013microbiota interaction induces bi-phasic inflammation and glucose intolerance in mice. Mol. Metab. 6, 1371\u20131380 (2017).","journal-title":"Mol. Metab."},{"key":"1600_CR22","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1111\/mmi.12067","volume":"86","author":"AV Bogachev","year":"2012","unstructured":"Bogachev, A. V., Bertsova, Y. V., Bloch, D. A. & Verkhovsky, M. I. Urocanate reductase: identification of a novel anaerobic respiratory pathway in Shewanella oneidensis MR-1. Mol. Microbiol. 86, 1452\u20131463 (2012).","journal-title":"Mol. Microbiol."},{"key":"1600_CR23","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jhep.2014.02.006","volume":"60","author":"P Fickert","year":"2014","unstructured":"Fickert, P. et al. Characterization of animal models for primary sclerosing cholangitis (PSC). J. Hepatol. 60, 1290\u20131303 (2014).","journal-title":"J. Hepatol."},{"key":"1600_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cmet.2020.07.012","volume":"32","author":"A Koh","year":"2020","unstructured":"Koh, A. et al. Microbial imidazole propionate affects responses to metformin through p38\u03b3-dependent inhibitory AMPK phosphorylation. Cell Metab. 32, 643\u2013653.e4 (2020).","journal-title":"Cell Metab."},{"key":"1600_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0009-8981(72)90317-8","volume":"39","author":"C van der Heiden","year":"1972","unstructured":"van der Heiden, C., Wadman, S. K., de Bree, P. K. & Wauters, E. A. Increased urinary imidazolepropionic acid, N-acetylhistamine and other imidazole compounds in patients with intestinal disorders. Clin. Chim. Acta Int. J. Clin. Chem. 39, 201\u2013214 (1972).","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"1600_CR26","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/hep.30210","volume":"69","author":"G Carpino","year":"2019","unstructured":"Carpino, G. et al. Neoplastic transformation of the peribiliary stem cell niche in cholangiocarcinoma arisen in primary sclerosing cholangitis. Hepatology 69, 622\u2013638 (2019).","journal-title":"Hepatology"},{"key":"1600_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/HEP.0000000000000373","volume":"78","author":"X Chao","year":"2023","unstructured":"Chao, X. et al. Persistent mTORC1 activation due to loss of liver tuberous sclerosis complex 1 promotes liver injury in alcoholic hepatitis. Hepatology 78, 503\u2013517 (2023).","journal-title":"Hepatology"},{"key":"1600_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2024.117038","volume":"490","author":"WH Abdulaal","year":"2024","unstructured":"Abdulaal, W. H. et al. Pirfenidone ameliorates ANIT-induced cholestatic liver injury via modulation of FXR, NF-\u043aB\/TNF-\u03b1, and Wnt\/GSK-3\u03b2\/\u03b2-catenin signaling pathways. Toxicol. Appl. Pharmacol. 490, 117038 (2024).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"1600_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1023\/A:1013240225965","volume":"47","author":"P Angulo","year":"2002","unstructured":"Angulo, P. et al. Pirfenidone in the treatment of primary sclerosing cholangitis. Dig. Dis. Sci. 47, 157\u2013161 (2002).","journal-title":"Dig. Dis. Sci."},{"key":"1600_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202101175","volume":"66","author":"J Wu","year":"2022","unstructured":"Wu, J. et al. Role of microbial metabolites of histidine in the development of colitis. Mol. Nutr. Food Res. 66, e2101175 (2022).","journal-title":"Mol. Nutr. Food Res."},{"key":"1600_CR31","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1136\/gutjnl-2022-328048","volume":"72","author":"A Vich Vila","year":"2023","unstructured":"Vich Vila, A. et al. Faecal metabolome and its determinants in inflammatory bowel disease. Gut 72, 1472\u20131485 (2023).","journal-title":"Gut"},{"key":"1600_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01296-6","volume":"16","author":"SC Raju","year":"2024","unstructured":"Raju, S. C. et al. Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity. Genome Med. 16, 27 (2024).","journal-title":"Genome Med."},{"key":"1600_CR33","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1093\/eurheartj\/ehaf661","volume":"47","author":"FA Wenzl","year":"2025","unstructured":"Wenzl, F. A. et al. Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease. Eur. Heart J. 47, 4259\u20134273 https:\/\/doi.org\/10.1093\/eurheartj\/ehaf661 (2025).","journal-title":"Eur. Heart J."},{"key":"1600_CR34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41586-025-09263-w","volume":"645","author":"A Mastrangelo","year":"2025","unstructured":"Mastrangelo, A. et al. Imidazole propionate is a driver and therapeutic target in atherosclerosis. Nature 645, 254\u2013261 (2025).","journal-title":"Nature"},{"key":"1600_CR35","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jhep.2013.11.017","volume":"60","author":"JF Ludvigsson","year":"2014","unstructured":"Ludvigsson, J. F., Bergquist, A., Montgomery, S. M. & Bahmanyar, S. Risk of diabetes and cardiovascular disease in patients with primary sclerosing cholangitis. J. Hepatol. 60, 802\u2013808 (2014).","journal-title":"J. Hepatol."},{"key":"1600_CR36","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1093\/infdis\/jiad604","volume":"229","author":"M Tr\u00f8seid","year":"2024","unstructured":"Tr\u00f8seid, M. et al. Gut microbiota alterations and circulating imidazole propionate levels are associated with obstructive coronary artery disease in people with HIV. J. Infect. Dis. 229, 898\u2013907 (2024).","journal-title":"J. Infect. Dis."},{"key":"1600_CR37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41522-024-00592-8","volume":"10","author":"MV Warmbrunn","year":"2024","unstructured":"Warmbrunn, M. V. et al. Kinetics of imidazole propionate from orally delivered histidine in mice and humans. npj Biofilms Microbiomes 10, 118 (2024).","journal-title":"npj Biofilms Microbiomes"},{"key":"1600_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21548-y","volume":"12","author":"R Venskutonyt\u0117","year":"2021","unstructured":"Venskutonyt\u0117, R. et al. Structural characterization of the microbial enzyme urocanate reductase mediating imidazole propionate production. Nat. Commun. 12, 1347 (2021).","journal-title":"Nat. Commun."},{"key":"1600_CR39","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.26565","volume":"58","author":"K Boonstra","year":"2013","unstructured":"Boonstra, K. et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 58, 2045\u20132055 (2013).","journal-title":"Hepatology"},{"key":"1600_CR40","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/j.jhep.2023.03.043","volume":"79","author":"P Fickert","year":"2023","unstructured":"Fickert, P., Lin, A. C., Ritschl, H., Hammer, N. & Denk, H. Portal venous branches as an anatomic railroad for a gut\u2013bile duct-axis. J. Hepatol. 79, e82\u2013e84 (2023).","journal-title":"J. Hepatol."},{"key":"1600_CR41","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.3390\/ijms19103188","volume":"19","author":"PS Tietz-Bogert","year":"2018","unstructured":"Tietz-Bogert, P. S. et al. Metabolomic profiling of portal blood and bile reveals metabolic signatures of primary sclerosing cholangitis. Int. J. Mol. Sci. 19, 3188 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"1600_CR42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12876-021-01930-2","volume":"21","author":"AH Ali","year":"2021","unstructured":"Ali, A. H. et al. The PSC scientific community resource: an asset for multi-omics interrogation of primary sclerosing cholangitis. BMC Gastroenterol. 21, 353 (2021).","journal-title":"BMC Gastroenterol."},{"key":"1600_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5152\/tjg.2025.24300","volume":"36","author":"H Eruzun","year":"2025","unstructured":"Eruzun, H. et al. Clinical and biochemical characteristics of a Danish and Turkish cohort of incident and prevalent patients with primary biliary cholangitis. Turk. J. Gastroenterol. 36, 241\u2013246 (2025).","journal-title":"Turk. J. Gastroenterol."},{"key":"1600_CR44","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/ecco-jcc\/jjaa232","volume":"15","author":"IL Monstad","year":"2021","unstructured":"Monstad, I. L. et al. Outcome of ulcerative colitis 20 years after diagnosis in a prospective population-based inception cohort from South-Eastern Norway, the IBSEN Study. J. Crohns Colitis 15, 969\u2013979 (2021).","journal-title":"J. Crohns Colitis"},{"key":"1600_CR45","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani, N. et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67, 328 (2018).","journal-title":"Hepatology"},{"key":"1600_CR46","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/rcm.4013","volume":"23","author":"\u00d8 Midttun","year":"2009","unstructured":"Midttun, \u00d8, Hustad, S. & Ueland, P. M. Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography\/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 23, 1371\u20131379 (2009).","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"1600_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1891-0","volume":"20","author":"DE Wood","year":"2019","unstructured":"Wood, D. E., Lu, J. & Langmead, B. Improved metagenomic analysis with Kraken 2. Genome Biol. 20, 257 (2019).","journal-title":"Genome Biol."},{"key":"1600_CR48","doi-asserted-by":"publisher","first-page":"D785","DOI":"10.1093\/nar\/gkab776","volume":"50","author":"DH Parks","year":"2022","unstructured":"Parks, D. H. et al. GTDB: an ongoing census of bacterial and archaeal diversity through a phylogenetically consistent, rank normalized and complete genome-based taxonomy. Nucleic Acids Res. 50, D785\u2013D794 (2022).","journal-title":"Nucleic Acids Res."},{"key":"1600_CR49","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2026.2655793","volume":"18","author":"M Nikolaidis","year":"2026","unstructured":"Nikolaidis, M. et al. Compositional and functional differences of gut microbiome and metabolome inform pathogenesis of cholestatic liver disease. Gut Microbes 18, 2655793 (2026).","journal-title":"Gut Microbes"},{"key":"1600_CR50","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/metabo10120486","volume":"10","author":"T Faquih","year":"2020","unstructured":"Faquih, T. et al. A workflow for missing values imputation of untargeted metabolomics data. Metabolites 10, 486 (2020).","journal-title":"Metabolites"},{"key":"1600_CR51","doi-asserted-by":"publisher","unstructured":"Braadland, P. pedbra\/ImP_PSC_paper: stable version for Nat Metab submission. Zenodo https:\/\/doi.org\/10.5281\/zenodo.21531744 (2026).","DOI":"10.5281\/zenodo.21531744"}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01600-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01600-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01600-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:29:29Z","timestamp":1790072969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01600-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1600"],"URL":"https:\/\/doi.org\/10.1038\/s42255-026-01600-1","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of the article initially published, the peer review and editor recognition statements were missing and have now been added to the HTML and PDF versions of the article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.B. is a co-founder and shareholder in Implexion Pharma and Roxbiosens, and receives research funds from BioGaia. A.M., A.C. and K.R.B. are shareholders in Implexion Pharma. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}